Sort
30,917 grants matching “tumor microenvironment”
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)AWARD OF TASK ORDER "OPTIMIZATION AND FURTHER DEVELOPMENT OF MESOTHELIN VACCINE FOR THE PREVENTION OF OVARIAN CANCER"
$712,240Nathalie Scholler · Sri International · N01 · FY2016 · CA
PRIMING THE TUMOR-IMMUNE MICROENVIRONMENT IMPROVES IMMUNE SURVEILLANCE OF CANCER STEM CELLS AND PREVENTS CANCER RECURRENCE
$712,126Scripps Research Institute · · FY2010 · Department of the Army
Human natural killer cells: Advancing biology and clinical applications
$712,108Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2019 · CA
The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression
$712,065John J Reilly · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL
Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy
$711,787Alexander Marson · J. David Gladstone Institutes · R01 · FY2024 · CA
LIGHT-ACTIVATED GENE EXPRESSION IN SINGLE CELLS WITHIN TISSUE
$711,684Robert H Singer · Albert Einstein College Of Medicine · R01 · FY2008 · GM
Molecular Phenotypes within and across disease boundaries in IPF and COPD
$711,424Naftali Kaminski · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · HL
Hematopathology Fellowship
$711,370Elaine Jaffe · Division Of Basic Sciences - Nci · ZIE · FY2009 · CA
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$711,323Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$711,319Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2020 · CA
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
$711,258Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
$711,171Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Development of a platform for spatial functional genomics
$711,098Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AT
Cancer Stem Cells in Cholangiocarcinoma
$711,015Changqing Xie · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Translating Behavioral Interventions for Health Disparity Populations
$710,893Anna Maria Napoles · National Institute On Minority Health And Health Disparities · ZIA · FY2021 · MD
Role of IKK alpha in lung cancer development
$710,843Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Systems biology of intratumoral heterogeneity in glioblastoma
$710,570Nitin S Baliga · Institute For Systems Biology · R01 · FY2024 · CA
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer livermetastasis
$710,138Wendy S. Garrett · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · CA
Exploring PSMA Biology in Tumor neovasculature
$709,876Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
$709,775Harriet M Kluger · Yale University · K12 · FY2022 · CA
Targeting Stoma-Tumor Co-Dependency for Glioma Therapy
$709,767David H. Gutmann · Washington University · U01 · FY2013 · CA
Neoadjuvant SEMA4D/ICB therapy for melanoma
$709,554Chrystal Mary Paulos · Emory University · R01 · FY2025 · CA
Attacking stress tolerance in cancer
$709,531David A Cheresh · University Of California, San Diego · R35 · FY2018 · CA
Systems Modeling of Tumor Heterogeneity and Therapy Response in Colorectal Cancer
$709,442Fiona Ginty · General Electric Global Research Ctr · R01 · FY2019 · CA
Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy
$709,419Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA